What is MedLink International Inc?
engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data.
MLKNA · Verdict
Strong reward · moderate risk
MLKNA stands out on growth and balance sheet, but watch the cash flow signal.
Based on 88% data coverage
MLKNA · Verdict
Revenue +177.7% CAGR
Current ratio 1.05
Above average
3% net margin
Model-based scoring. For information only — not financial advice.
engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data. The company offers MedLink iSuite EHR that automates physician activities, such as prescribing, dictating, ordering lab tests and viewing results, documenting clinical encounters, and capturing charges, among others; and MedLink IX (Information eXchange), an enterprise connectivity solution that links providers and healthcare services to achieve interoperability deployed in commercial and hospital laboratories. The company is listed on the OTCCE in USA, operating in the Healthcare sector, with a market capitalisation of 4.76K.
The scoring profile indicates a strong reward potential, driven primarily by growth and profitability. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.